Skip to main content
search
Tag

NICE

HighlightsHighlights Archive

NICE: Hundreds of diabetic children to avoid finger-prick testing through two technologies

For the first time new guidance from NICE recommends the use of real-time continuous glucose monitoring (rtCGM) or intermittently scanned glucose monitoring (isCGM) devices for some children living with type 2 diabetes who are currently using finger prick testing and insulin therapy. NICE’s committee was told that children being offered the technology would be subjected to the ‘burdensome’, ‘tiring’, and…
Dawn
May 12, 2023
Membership NewsMembership News Archive

NICE recommends BIVDA member Genedrive’s test

BIVDA is delighted that Genedrive’s genetic test has been officially recommended for use in NICE’s final guidance. The assessment of the test was carried out carried out through NICE’s Early Value Assessment pilot project, which aims to enable earlier access to digital products, medical devices and diagnostics that address national unmet needs in health and social care. We hope to see many more…
Natalie Creaney
April 6, 2023
Membership NewsMembership News Archive

NICE Updates

Evidence standards framework (ESF) for digital health technologies NICE have updated their ESF for digital health technologies. It now includes new evidence requirements for artificial intelligence and data-driven products. They’ve also aligned the classification of technologies with regulatory requirements and made it easier to use. The framework aims to guide developers in generating high quality evidence. It also helps commissioners…
Natalie Creaney
September 23, 2022
ConsultationsConsultations Archive

NICE: Help shape our new regulatory service

NICE has launched an early version of their new service which maps out the regulatory and health technology assessment pathway for AI and digital technologies. They invite interested parties whether you are an adopter or developer – looking to either create or implement new technologies – to ‘test’ the site and provide feedback. The website, titled ‘Understanding regulations of AI…
Natalie Creaney
August 19, 2022
ConsultationsConsultations Archive

NICE guideline on Urinary tract infection in under 16s: diagnosis and management

This final guideline has now been published on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments that we received during consultation and the responses to these comments. NICE have also produced an equality impact assessment to support the guideline. There is brief information about the guideline for people…
Michael
August 12, 2022
HighlightsHighlights Archive

NICE update their pre-eclampsia guidance to improve diagnoses

NICE have released new guidance which recommends the routine use of placental growth factor-based tests (PLGF) to better diagnose pre-eclampsia. This move could lead to better outcomes for thousands of babies and their mothers in the future. Pre-eclampsia affects one out of 10 pregnancies and often leads to serious complications if left untreated. Four PLGF tests have been proffered to…
Natalie Creaney
July 29, 2022
ConsultationsConsultations Archive

Consultation on NICE guidelines related to fluid therapy in children and young people

NICE will shortly commence a 2-week consultation with registered stakeholders about the need to update a number of guidelines related to fluid therapy in children and young people. The consultation will be open from Wednesday 3rd August until Friday 19th August 2022. The consultation will consider these areas of guidance related to our sector: Sepsis: Recognition, diagnosis and early management…
Natalie Creaney
July 22, 2022
ConsultationsConsultations Archive

NICE Consultations on Diabetes & UTIs

NICE is working on Consultation processes and updates regarding Diabetes in adults and urinary tract infections. Please find the information here on the Consultation regarding Diabetes in adults - Type 1 and Type 2. Please find the information here on the Consultation regarding urinary tract infections. The closing date for comments on both Consultations is: Friday 10 June 2022.
Michael
June 1, 2022
HighlightsHighlights Archive

NICE undertakes world-first evaluation of antimicrobial drugs to tackle AMR

In a historic move, cefiderocol and ceftazidime–avibactam will become the first antimicrobial drugs authorised by NICE for use in the UK’s new subscription-style payment model. This forms part of a larger scheme with NHSE/I and DHSC to provide a greater incentive to research and develop much-needed antimicrobial drugs for the future. The dearth of new antimicrobials being developed and the…
Ben Kemp
April 14, 2022
Close Menu